Partial alanine scan of mast cell degranulating peptide (MCD): Importance of the histidine- and arinine residues

Journal of Peptide Science

Volumn 10, Issue 6, 2004, Pages 313-317

  Buku, Angeliki ^a   Mendlowitz, Milton ^a   Condie, Barry A ^b   Price, Joseph A ^c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b WISTAR INSTITUTE   (United States)

^c OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

Ala scan; Flourescence polarization; Histamine release; Mast cell receptor; MCD

Indexed keywords

ALANINE; ALANINE DERIVATIVE; AMINO ACID; ARGININE; ARGININE DERIVATIVE; CELL RECEPTOR; FC RECEPTOR; HISTIDINE; HISTIDINE DERIVATIVE; IMMUNOGLOBULIN E RECEPTOR; MAST CELL DEGRANULATING PEPTIDE; RECEPTOR SUBUNIT;

AMINO ACID ANALYSIS; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; CONTROLLED STUDY; FLUORESCENCE POLARIZATION; HISTAMINE RELEASE; NONHUMAN; PERITONEUM MAST CELL; PRIORITY JOURNAL; PROTEIN BINDING; RAT; RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION;

ALANINE; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; ARGININE; BINDING, COMPETITIVE; FLUORESCENCE POLARIZATION; HISTAMINE RELEASE; HISTIDINE; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; PEPTIDES; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, IGE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 3042665907     PISSN: 10752617     EISSN: None     Source Type: Journal    
DOI: 10.1002/psc.532     Document Type: Article

References (31)

1. Buku A. Mast cell degranulating peptide: A prototypic peptide in allergy and inflammation. Peptides 1999; 20: 415-420.
2. Habermann E. Bee and wasp venom. Science 1972; 177: 31.
3. Billingham MEJ, Morley J, Hanson JM, Shipolini EA, Vernon CA. An anti-inflammatory peptide from bee venom. Nature 1973; 244: 163-164.
4. Hanson JM, Morley J, Soria-Herrera C. Anti-inflammatory property of 401(MCD peptide): a peptide from the bee venom. Br. J. Pharmacol. 1974; 50: 383-392.
5. Ishizaka T, Ishizaka K. Activation of mast cell for mediator release through IgE receptors. Progr. Allergy 1984; 34: 188-235.
6. Buku A, Price JA, Mendlowitz M, Masur S. Mast cell degranulating peptide binds to RBL-2H3 mast cell receptors and inhibits IgE binding. Peptides 2001; 22: 1993-1998.
7. Cochrane DE. Peptide regulation of mast-cell function. Progr. Med. Chem. 1990; 27: 143-189.
8. Buku A, Mirza U, Polewski K. Circular dichroism (CD) studies on biological activity of mast cell degranulating (MCD) peptide analogs. Int. J. Peptide Prot. Res. 1994; 44: 410-413.
9. Buku A, Maulik G, Hook WA. Bioactivities and secondary structure of mast cell degranulating (MCD) peptide analogs. Peptides 1998; 19: 1-5.
10. Buku A, Price JA. Further studies of the structural requirements of mast cell degranulating (MCD) peptide-mediated histamine release. Peptides 2001; 22: 1987-1991.
11. Buku A. Mendlowitz M, Condie BA, Price JA. Histamine-releasing activity and binding to the FceRIa mast cell receptor subunit of mast cell degranulating (MCD) peptide analogs with alanine substitutions. J. Med. Chem. 2003; 46: 3008-3012.
12. Buku A, Blandina P, Birr C, Gazis D. Solid phase synthesis and biological activity of mast cell degranulating (MCD) peptide: A component of bee venom. Int. J. Peptide Prot. Res. 1989; 33: 86-99.
13. Buku A, Reibman J, Pistelli A, Blandina P, Gazis D. Mast cell degranulating (MCD) peptide analogs with reduced ring structure. J. Prot. Chem. 1992; 11: 275-280.
14. Price JA. Microplate assay for measurement of histamine release from mast cells. BioTechniques 1997; 22: 958-962.
15. Price JA. Two layer gradient isolation of rat peritoneal cells. BioTechniques 1997; 22: 616-618.
16. Shore PA. Fluorometric assay of histamine. Methods Enzymol. 1971; 17: 842-845.
17. Otvos L Jr, Insug O, Rogers ME, Consolvo PJ, Condie B, Lovas S, Bulet P, Blaszczyk-Thurin MA. Interaction between heat shock proteins and antimicrobial peptides. Biochemistry 2000; 39: 14 150-14 159.
18. Allen M, Reeves J, Mellor G. High throughput fluorescence polarization: A homogeneous alternative to radioligand binding for cell surface receptors. J. Biomolec. Screening 2000; 5: 63-69.
19. Lundblad JR, Laurance M, Goodman RH. Fluorescence polarization analysis of protein-DNA and protein-protein interactions. Mol. Endocrinol. 1996; 10: 607-621.
20. Wu P, Brasseur M, Schindler UA. High throughput STAT binding assay using fluorescence polarization. Anal. Biochem. 1977; 249: 29-36.
21. Helm BA, Spivey AC, Padlan EA. Peptide blocking of IgE/receptor interaction: Possibilities and pitfalls. Br. J. Pharmacol. 1997; 52: 1155-1169.
22. McDonell JM, Beavil AJ, Mackay GA, Jameson BA, Korngold R, Gould HJ, Sutton BJ. Structure based design and characterization of peptides that inhibit IgE binding to its high-affinity receptor. Nature, Struct. Biol. 1996; 3: 419-426.
23. Nakamura GR, Starovasnik MA, Reynolds ME, Lowman HBA. Novel family of hairpin peptides that inhibit IgE activity by binding to the high-affinity IgE receptor. Biochemistry 2001; 40: 9828-9835.
24. 5 receptors of γ -MSH analogs substituted with L-alanine. J. Peptide Res. 2002; 59: 203-210.
25. Liu IP, Deber CM. Guidelines for membrane protein engineering derived of from de novo designed model peptides. Biopolymers 1998; 47: 41-62.
26. Chou PY, Fasman GD. Prediction of the secondary structure of proteins from their amino acid sequence. Adv. Enzymol. 1978; 47: 45-148.
27. Unson CG, Macdonald D, Merrifield RB. The role of histidine 1 in glucagons action. Arch. Biochem. Biophys. 1993; 300: 747-750.
28. Taylor JW, Bidard JN, Lazdunski M. The characterization of high affinity binding sites in rat brain for the mast cell degranulating peptide from bee venom using a monoiodinated peptide. J. Biol. Chem. 1984; 259: 13 957-13 967.
29. Garman SC, Kinet JP, Jardetzky TS. Crystal structure of the human high affinity IgE receptor. Cell 1998; 95: 951-961.
30. Garman SC, Wurzburg BA, Tarchevskaya S, Kinet JP, Jardetzky TS. Structure of the Fc fragment of human IgE bound to its high-affinity receptor. Nature 2000; 406: 259-266.
31. Hakimi J, Seals C, Kondas JA, Pettine I, Dahno W, Kochan J. The α-subunit of the human IgE receptor (FcERI) is sufficient for high affinity IgE binding. J. Biol. Chem. 1990; 265: 22 079-22 081.